| COVID-19 in patients with Behçet’s disease: Outcomes and rate of Behçet’s exacerbations in a retrospective cohort B Polat, A Erden, SC Güven, B Armağan, Ö Karakaş, B Özdemir, ... Modern rheumatology 32 (2), 455-459, 2022 | 13 | 2022 |
| Effects of anti‐SARS‐CoV‐2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort H Apaydin, A Erden, SC Güven, B Armağan, HE Konak, B Polat, Y Afşin, ... International Journal of Rheumatic Diseases 25 (9), 1068-1077, 2022 | 10 | 2022 |
| Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study Ö Karakaş, A Erden, B Armağan, SC Güven, E Atalar, B Polat, A Omma, ... International Journal of Rheumatic Diseases 26 (2), 292-297, 2023 | 5 | 2023 |
| Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: Experience of a single center HE Konak, B Armağan, SC Güven, E Atalar, Ö Karakaş, S Esmer, ... Romanian Journal of Internal Medicine 60 (3), 173-181, 2022 | 4 | 2022 |
| Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease A Erden, H Apaydın, A Fanouriakis, SC Güven, B Armagan, P Akyüz Dağlı, ... Rheumatology 61 (9), 3606-3613, 2022 | 4 | 2022 |
| Clinical course of idiopathic inflammatory myopathies in the COVID-19 pandemic: a single-center experience H Apaydin, A Erden, SC Güven, B Armağan, Ö Karakaş, B Özdemir, ... Future Virology 17 (8), 545-556, 2022 | 1 | 2022 |
| COVID-19 in Patıents Wıth Behcet’s Dısease: Outcomes and Rate of Behçet’s Exacerbatıons ın a Retrospectıve Cohort B Polat, A Erden, SC Güven, B Armağan, Ö Karakaş, B Özdemir, ... Modern Rheumatology, 2021 | 1 | 2021 |
| AB1586-HPR REASONS FOR STOPPING HYDROXYCHLOROQUINE: DO WE GIVE UP EASILY? B Armagan, HE Konak, E Atalar, BÖ Ulusoy, PA Dağli, Ö Karakaş, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2167-2168, 2024 | | 2024 |
| AB1345 COMORBIDITY PROFILES IN INFLAMMATORY RHEUMATIC DISEASES: AN ANALYTICAL PERSPECTIVE RK Ulucaköy, H Babaoglu, EK Erdoğan, K Orhan, E Atalar, SC Güven, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2024 | | 2024 |
| Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post-Coronavirus Disease 2019 Proteinuria Progression SC Güven, A Erden, H Küçük, H Apaydın, B Polat, RC Kardaş, D Yıldırım, ... Hypertension 12, 75.0, 2024 | | 2024 |
| AB1059 NETRIN-1 IN SPONDYLOARTHRITIS: A NOVEL MARKER TO PREDICT DISEASE ACTIVITY? F Baykal, S Erten, SC Güven, A Kor, F Eren, S Neşelioğlu, B Polat, K Gok, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1751-1751, 2023 | | 2023 |
| Behçet hastalarında vasküler tutulumda erektil disfonksiyon. B Polat, A Erden, S Ünal, B Armağan, SC Güven, E Okulu, A Omma, ... Journal of Turkish Society for Rheumatology 14, 2022 | | 2022 |
| COVID-19 infection may trigger SLE disease: A case report E ATALAR, Y MARAŞ, N SÜNGÜ, ŞK CEVHER, M KELEŞ, B POLAT Journal of Experimental and Clinical Medicine 39 (3), 901-903, 2022 | | 2022 |
| POS1250 EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY. Ö Karakaş, A Erden, B Armagan, SC Güven, E Atalar, B Polat, A Omma, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 960-960, 2022 | | 2022 |
| POS1280 EFFECTS OF ANTI-SARS-CoV-2 VACCINATION ON SAFETY AND DISEASE EXACERBATION IN BEHCET’S DISEASE PATIENTS: A SINGLE CENTRE STUDY H Apaydin, A Erden, B Armagan, SC Güven, HE Konak, Y Afşin, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 977-977, 2022 | | 2022 |
| 960 Scientific Abstracts Ö Karakaş, A Erden, B Armagan, SC Güven, E Atalar, B Polat, A Omma, ... Hypertension 6, 17.1, 0 | | |
